Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic ResponsesJonathan B. Mitchem, David G. DeNardo, Donal J. Brennan et al.|Cancer Research|2012Cited by 941
Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and BiomarkersHelena C. Bartels, Donal J. Brennan, James D. Postle et al.|Disease Markers|2018Cited by 244
CA IX is an Independent Prognostic Marker in Premenopausal Breast Cancer Patients with One to Three Positive Lymph Nodes and a Putative Marker of Radiation ResistanceDonal J. Brennan, Sallyann L. O’Brien|Clinical Cancer Research|2006Cited by 138
Association of Implementing a Multidisciplinary Team Approach in the Management of Morbidly Adherent Placenta With Maternal Morbidity and MortalityHelena C. Bartels, Donal J. Brennan, Ailín C. Rogers et al.|Obstetrics and Gynecology|2018Cited by 65
Cesarean scar niche: An evolving concern in clinical practiceFionnvola Armstrong, Donal J. Brennan, Karen Mulligan et al.|International Journal of Gynecology & Obstetrics|2022Cited by 62